SCHEMBL26833746

SCHEMBL26833746

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ccc8c(n7)sc7ccccc78)cc6)c6ccc(-c7ccc8c(n7)sc7ccccc78)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ SMN1; SMN2 Q16637 4/20 0.32
▸ NPC1 O15118 4/20 0.32
▸ RAB9A P51151 4/20 0.32
▸ NFKB1 P19838 2/20 0.32
▸ NFKB2 Q00653 2/20 0.32
▸ RELA Q04206 2/20 0.32
▸ LIMK1 P53667 2/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ AR P10275 1/20 0.32
▸ GFER P55789 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ ELANE P08246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663228 0.94 ALDH1A1 (0.36) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663224 0.93 RAB9A (0.33) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL24055544 0.92 CYP1A1 (0.37) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663226 0.91 RAB9A (0.33) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL26834174 0.90 NPC1 (0.37) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL26833773 0.87 CYP1A2 (0.35) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663221 0.87 RAB9A (0.39) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL26833754 0.85 CYP1A2 (0.33) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663220 0.84 RAB9A (0.38) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663222 0.84 RAB9A (0.35) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 ALDH1A1 1797/4885CYP1A2 122/4885HPGD 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback